Nitrogen monoxide production suppressor
AssigneeNippon Zoki Pharmaceutical Co., Ltd.
InventorsKousaku Ohno, Jin-emon Konishi, Seishi Suehiro
Life of this patent
Estimating the term…
Loading patent…
AssigneeNippon Zoki Pharmaceutical Co., Ltd.
InventorsKousaku Ohno, Jin-emon Konishi, Seishi Suehiro
Estimating the term…
A pharmaceutical composition containing an extract from inflammatory tissue inoculated with vaccinia virus may be used to suppress the death of cells caused by endotoxin, and suppress excessive production of nitrogen monoxide induced by endotoxin. The extract may also be used to relieve hypotension induced by endotoxin. In sepsis and other serious bacterial infectious diseases, endotoxin (an intracellular toxin) is produced and a shock symptom is induced by its action. The extract, having an excellent inhibitory action toward endotoxin-induced toxicity, is quite useful for the treatment or the prevention of endotoxin-induced shock symptoms, sepsis and various symptoms accompanied thereby. In addition, the extract has an inhibitory action towards abnormal nitrogen monoxide production during the diseased state and, therefore, it is also useful as a therapeutic and preventive agent for diseases wherein an excessive nitrogen monoxide production occurs, such as acute hypotension.
A method for the treatment of sepsis comprising administering to a patient in need of such treatment a pharmaceutically effective amount of an extract from inflammatory tissue inoculated with vaccinia virus.
A method for inhibiting endotoxin production in a patient afflicted with an endotoxin-producing disease comprising administering to said patient a pharmaceutically effective amount of an extract from inflammatory tissue inoculated with vaccinia virus.
A method for treating endotoxin shock comprising administering to a patient in need of such treatment a pharmaceutically effective amount of an extract from inflammatory tissue inoculated with vaccinia virus.
A method for treating hypotension caused by production of abnormal levels of nitrogen monoxide comprising administering to a patient in need of such treatment a pharmaceutically effective amount of an extract from inflammatory tissue inoculated with vaccinia virus.
Dependencies are inferred from the claim text.